FDA Approves Novartis Drug Cosentyx for Hidradenitis Suppurativa Treatment on November 01, 2023 Autoimmune Disorder Biologic Treatment Clinical Trials Cosentyx FDA Healthcare News. Hidradenitis Suppurativa Inflammatory Diseases Novartis Skin Condition +